CycleLife, LLC – Trademark Portfolio

Entity Type: 16

CycleLife, LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 5 Nice Classification classes. The owner is based in Washington, DC.

3255 K Street, NW

Washington, DC 20008

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CycleLife, LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

37
Building & Construction (2 filings)

Building construction; repair; installation services

39
Transportation & Storage (2 filings)

Transport; packaging and storage of goods; travel arrangement

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does CycleLife, LLC have?

CycleLife, LLC has 2 U.S. trademarks filed with the USPTO.

What trademark classes does CycleLife, LLC file in?

CycleLife, LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is CycleLife, LLC's trademark registration success rate?

CycleLife, LLC has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.